There is a need for new systemic sclerosis subset criteria. A content analytic approach

References

• Johnson SR, Feldman BM, Hawker GA. Classification criteria for systemic sclerosis subsets. J Rheumatol 2007;34:1855–63.
   PubMed Web of Science ®Google Scholar
• Barnett AJ, Coventry DA. Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases. Med J Aust 1969;1:992–1001.
   PubMed Web of Science ®Google Scholar
• Goetz R, Berne M. The pathophysiology of progressive systemic sclerosis (generalised scleroderma) with special reference to changes in the viscere. Clin Proc 1945;4:337–92.
   Google Scholar
• Goetz RH. The pathophysiology of progressive systemic sclerosis (generalized scleroderma) with special reference to changes in the fiscera. Cape Town Post Graduate Med Assoc 1945;4:337–92.
   Google Scholar
• Winterbauer RH. Multiple telengiectasia, raynaud’s phenomenon, sclerodactyly, and subcutaneous calcinosis: A syndrome mimicking hereditary hemorrhagic telengiectasia. Bull Johns Hopkins Hosp 1964;114:361–83.
   PubMedGoogle Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TAJr., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.
   PubMed Web of Science ®Google Scholar
• Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 1986;13:911–16.
   PubMed Web of Science ®Google Scholar
• Giordano M, Ara M, Capelli L, Tirri G, Vatti M. Variability of the clinical picture and the classification of progressive systemic scleroderma. ZRheumatol 1976;35:286–300.
   Google Scholar
• Tuffanelli DL, Winkelmann RK. Diffuse systemic scleroderma. A comparison with acrosclerosis. Ann Intern Med 1962;57:198–203.
   PubMed Web of Science ®Google Scholar
• Rodnan GP, Jablonska S, Medsger TA. Classification and nomenclature of progressive systemic sclerosis. Clin Rheumatic Dis 1979;5:5–13.
   Google Scholar
• Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:139–53.
   PubMed Web of Science ®Google Scholar
• Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002;81:154–67.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573–6.
   PubMed Web of Science ®Google Scholar
• Holzmann H, Sollberg S, Altmeyer P. Classification of progressive systemic scleroderma. Hautarzt 1987;38:253–7.
   PubMed Web of Science ®Google Scholar
• Masi AT. Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 1988;15:894–8.
   PubMed Web of Science ®Google Scholar
• Maricq HR, Valter I. A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 2004;22:(Suppl 33):S5-13.
   PubMed Web of Science ®Google Scholar
• Cottrell TR, Wise RA, Wigley FM, Boin F. The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis. Ann Rheum Dis 2014;73:1060–6.
   PubMed Web of Science ®Google Scholar
• Patterson KA, Roberts-Thomson PJ, Lester S, Tan JA, Hakendorf P, Rischmueller M, et al. Interpretation of an extended autoantibody profile in a well-characterized australian systemic sclerosis (scleroderma) cohort using principal components analysis. Arthritis Rheumatol 2015;67:3234–44.
   PubMed Web of Science ®Google Scholar
• Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988;15:276–83.
   PubMed Web of Science ®Google Scholar
• Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682–6.
   PubMed Web of Science ®Google Scholar
• Matucci-Cerinic M, Bellando-Randone S, Lepri G, Bruni C, Guiducci S. Very early versus early disease: the evolving definition of the ‘many faces’ of systemic sclerosis. Ann Rheum Dis 2013;72:319–21.
   PubMed Web of Science ®Google Scholar
• Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirjak L, et al. Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis 2014;73:2087–93.
   PubMed Web of Science ®Google Scholar
• Johnson S, Khanna D, Allanore Y, Matucci-Cerinic M, Furst D. Systemic sclerosis trial design moving forward. J scleroderma relat disord 2016;1:177–80
   PubMed Web of Science ®Google Scholar
• Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA Jr. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007;34:104–9.
   PubMed Web of Science ®Google Scholar
• Fertig N, Domsic RT, Rodriguez-Reyna T, Kuwana M, Lucas M, Medsger TA Jr., et al. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Rheum 2009;61:958–65.
   PubMed Web of Science ®Google Scholar
• Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. Plos Genet 2011;7:e1002178.
   PubMed Web of Science ®Google Scholar
• Van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, et al. Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis. N Engl J Med 2014;370:433–43.
   PubMed Web of Science ®Google Scholar
• Johnson SR, Tomlinson GA, Hawker GA, Granton JT, Feldman BM. Methods to elicit beliefs for Bayesian priors: a systematic review. J Clin Epidemiol 2010;63:355–69.
   PubMed Web of Science ®Google Scholar
• Johnson SR, Granton JT, Tomlinson GA, Grosbein HA, Le T, Lee P, et al. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease. J Rheumatol 2012;39:276–85.
   PubMed Web of Science ®Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006;18:59–82.
   Web of Science ®Google Scholar
• Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15:1277–88.
   PubMed Web of Science ®Google Scholar
• Nakayama A, Tunnicliffe DJ, Thakkar V, Singh-Grewal D, O’Neill S, Craig JC, et al. Patients’ perspectives and experiences living with systemic sclerosis: a systematic review and thematic synthesis of qualitative studies. J Rheumatol 2016;43:1363–75.
   PubMed Web of Science ®Google Scholar
• Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, et al. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Arthritis Rheum 2007;56:2422–31.
   PubMed Web of Science ®Google Scholar
• Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001;44:2828–35.
   PubMed Web of Science ®Google Scholar
• Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 2011;70:104–9.
   PubMed Web of Science ®Google Scholar
• Ligon CB, Wigley FM. Editorial: scleroderma: bringing a disease from black-and-white into technicolor. Arthritis Rheumatol 2015;67:3101–3.
   PubMed Web of Science ®Google Scholar
• Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737–47.
   PubMed Web of Science ®Google Scholar
• Domsic RT. Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement. Curr Opin Rheumatol 2014;26:646–52.
   PubMed Web of Science ®Google Scholar
• Borsboom D, Mellenbergh GJ, Van Heerden J. The theoretical status of latent variables. Psychol Rev 2003;110:203–19.
   PubMed Web of Science ®Google Scholar
• Duffy CM, Feldman BM. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, editors. Textbook of Pediatric Rheumatology, 7th edn. Philadelphia, PA: Elsevier, 2016. 78–87.e5.
   Google Scholar
• Johnson SR. New ACR EULAR guidelines for systemic sclerosis classification. Curr Rheumatol Rep 2015;17:32.
   PubMed Web of Science ®Google Scholar
• Johnson SR, O’Brien KK. Qualitative methods in systemic sclerosis research. J Rheumatol 2016;43:1265–7.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 2015;67:891–7.
   PubMed Web of Science ®Google Scholar
• Johnson SR, Goek ON, Singh-Grewal D, Vlad SC, Feldman BM, Felson DT, et al. Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum 2007;57:1119–33.
   PubMed Web of Science ®Google Scholar